Cargando…
Evolution of drug resistance in HIV protease
BACKGROUND: Drug resistance is a critical problem limiting effective antiviral therapy for HIV/AIDS. Computational techniques for predicting drug resistance profiles from genomic data can accelerate the appropriate choice of therapy. These techniques can also be used to identify protease mutants for...
Autores principales: | Shah, Dhara, Freas, Christopher, Weber, Irene T., Harrison, Robert W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7772915/ https://www.ncbi.nlm.nih.gov/pubmed/33375936 http://dx.doi.org/10.1186/s12859-020-03825-7 |
Ejemplares similares
-
Analysis of drug resistance in HIV protease
por: Pawar, Shrikant D., et al.
Publicado: (2018) -
HIV-1 Protease: Structural Perspectives on Drug Resistance
por: Weber, Irene T., et al.
Publicado: (2009) -
Highly Drug-Resistant HIV-1 Protease Mutant
PRS17 Shows Enhanced Binding to Substrate Analogues
por: Agniswamy, Johnson, et al.
Publicado: (2019) -
Identifying representative drug resistant mutants of HIV
por: Yu, Xiaxia, et al.
Publicado: (2015) -
HIV Protease: Historical Perspective and Current Research
por: Weber, Irene T., et al.
Publicado: (2021)